Attention-deficit/hyperactivity disorder medications and long-term risk of cardiovascular diseases

L Zhang, L Li, P Andell, M Garcia-Argibay… - JAMA …, 2024 - jamanetwork.com
Importance Use of attention-deficit/hyperactivity disorder (ADHD) medications has increased
substantially over the past decades. However, the potential risk of cardiovascular disease …

Effect of methylphenidate on height in pediatric attention-deficit hyperactivity disorder patients: a systematic review and meta-analysis

KL Duong, BR Yang, H Yun, J Chae - European Child & Adolescent …, 2023 - Springer
Abstract Methylphenidate (MPH), a first-line treatment for attention-deficit hyperactivity
disorder (ADHD) management, has been the focus of debate for decades regarding its effect …

A systematic review of pharmacotherapy for attention-deficit/hyperactivity disorder in children and adolescents with bipolar disorders

A Pouchon, R Nasserdine, C Dondé… - Expert Opinion on …, 2023 - Taylor & Francis
Introduction The data suggests that in children and adolescents, bipolar disorder (BD) and
attention deficit hyperactivity disorder (ADHD) may be strongly correlated. Even though …

ADHD medication discontinuation and persistence across the lifespan: a retrospective observational study using population-based databases

I Brikell, H Yao, L Li, A Astrup, L Gao, MB Gillies… - The Lancet …, 2024 - thelancet.com
Background Although often intended for long-term treatment, discontinuation of medication
for ADHD is common. However, cross-national estimates of discontinuation are missing due …

WHO Model Lists of Essential Medicines: methylphenidate for ADHD in children and adolescents

S Cortese, D Coghill, GW Mattingly, LA Rohde… - The Lancet …, 2023 - thelancet.com
Davide Papola and colleagues1 reviewed the applications of mental health treatments
submitted to the 24th WHO Expert Committee on the Selection and Use of Essential …

Pharmacotherapy for ADHD in children and adolescents: A summary and overview of different European guidelines

L Van Vyve, B Dierckx, CG Lim, M Danckaerts… - European Journal of …, 2024 - Springer
Attention deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder
characterized by a persistent pattern of inattention, hyperactivity, and impulsivity. It is the …

[HTML][HTML] Perspectives on ADHD in children and adolescents as a social construct amidst rising prevalence of diagnosis and medication use

T Banaschewski, A Häge, S Hohmann… - Frontiers in …, 2024 - frontiersin.org
The diagnosis of attention-deficit hyperactivity disorder (ADHD) is based on the presence of
pervasive, persistent symptoms of inattention and/or hyperactivity/impulsivity typically …

The Impact of Methylphenidate on Pubertal Maturation and Bone Age in ADHD Children and Adolescents: Results from the ADHD Drugs Use Chronic Effects …

S Carucci, A Zuddas, A Lampis… - Journal of Attention …, 2024 - journals.sagepub.com
Objective: The short-term safety of methylphenidate (MPH) has been widely demonstrated;
however the long-term safety is less clear. The aim of this study was to investigate the safety …

Psychopharmacology in children and adolescents: unmet needs and opportunities

S Cortese, D Purper-Ouakil, A Apter, C Arango… - The Lancet …, 2024 - thelancet.com
Psychopharmacological treatment is an important component of the multimodal intervention
approach to treating mental health conditions in children and adolescents. Currently, there …

Treatment of Aggressive Behavior and Agitation in an 11-Year-Old Boy with Co-Occurring Autism and ADHD: A Case Report and Literature Review on the Use of …

A Carta, V Cavassa, MV Puci, R Averna… - Journal of Clinical …, 2024 - mdpi.com
Background: Autism spectrum disorder (ASD) is a persistent neurodevelopmental disorder
frequently co-occurring with attention-deficit/hyperactivity disorder (ADHD) and behavior …